Deconvoluting lipid nanoparticle structure for messenger RNA delivery Y Eygeris, S Patel, A Jozic, G Sahay Nano letters 20 (6), 4543-4549, 2020 | 237 | 2020 |
Engineering lipid nanoparticles for enhanced intracellular delivery of mRNA through inhalation J Kim, A Jozic, Y Lin, Y Eygeris, E Bloom, X Tan, C Acosta, ... ACS nano 16 (9), 14792-14806, 2022 | 75 | 2022 |
Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery M Herrera, J Kim, Y Eygeris, A Jozic, G Sahay Biomaterials science 9 (12), 4289-4300, 2021 | 64 | 2021 |
Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates M Herrera-Barrera, RC Ryals, M Gautam, A Jozic, M Landry, T Korzun, ... Science advances 9 (2), eadd4623, 2023 | 57 | 2023 |
Naturally derived membrane lipids impact nanoparticle-based messenger RNA delivery J Kim, A Jozic, G Sahay Cellular and molecular bioengineering 13, 463-474, 2020 | 50 | 2020 |
Rapid Generation of Circulating and Mucosal Decoy Human ACE2 using mRNA Nanotherapeutics for the Potential Treatment of SARS‐CoV‐2 J Kim, A Jozic, A Mukherjee, D Nelson, K Chiem, MSR Khan, JB Torrelles, ... Advanced Science 9 (35), 2202556, 2022 | 36* | 2022 |
Leveraging biological buffers for efficient messenger RNA delivery via lipid nanoparticles MI Henderson, Y Eygeris, A Jozic, M Herrera, G Sahay Molecular pharmaceutics 19 (11), 4275-4285, 2022 | 14 | 2022 |
Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina M Gautam, A Jozic, GLN Su, M Herrera-Barrera, A Curtis, S Arrizabalaga, ... Nature communications 14 (1), 6468, 2023 | 6 | 2023 |
Strategies for non-viral vectors targeting organs beyond the liver J Kim, Y Eygeris, RC Ryals, A Jozić, G Sahay Nature Nanotechnology, 1-20, 2023 | 5 | 2023 |
Thiophene-based lipids for mRNA delivery to pulmonary and retinal tissues Y Eygeris, M Gupta, J Kim, A Jozic, M Gautam, J Renner, D Nelson, ... Proceedings of the National Academy of Sciences 121 (11), e2307813120, 2024 | 4 | 2024 |
mRNA vaccine against fibroblast activation protein ameliorates murine models of inflammatory arthritis X Zhang, A Jozic, P Song, Q Xu, X Shi, H Wang, L Bishop, HM Struthers, ... Rheumatology and Immunology Research 4 (2), 90-97, 2023 | 4 | 2023 |
Rapid generation of circulating and mucosal decoy ACE2 using mRNA nanotherapeutics for the potential treatment of SARS-CoV-2 (preprint) J Kim, A Mukherjee, D Nelson, A Jozic, G Sahay | 1 | 2020 |
A new era of targeting cystic fibrosis with non-viral delivery of genomic medicines NTV Murthy, K Vlasova, J Renner, A Jozic, G Sahay Advanced Drug Delivery Reviews, 115305, 2024 | | 2024 |
Microfluidic Platform Enables Shearless Aerosolization of Lipid Nanoparticles for mRNA Inhalation J Kim, A Jozić, E Bloom, B Jones, M Marra, NTV Murthy, Y Eygeris, ... ACS nano, 2024 | | 2024 |
Abstract LB019: Comprehensive therapeutic impact: Follistatin mRNA-loaded lipid nanoparticles halt lung metastases and prolong survival in murine head & neck squamous cell … O Taratula, T Korzun, A Jozic, V Grigoriev, G Sahay, DL Marks Cancer Research 84 (7_Supplement), LB019-LB019, 2024 | | 2024 |
Microfluidic platform enables shear-less aerosolization of lipid nanoparticles for messenger RNA inhalation J Kim, A Jozic', E Bloom, B Jones, M Marra, NTV Murthy, Y Eygeris, ... bioRxiv, 2024.01. 17.576136, 2024 | | 2024 |
Optimizing lipid nanoparticle-mediated photoreceptor transfection in the nonhuman primate. RC Ryals, M Gautam, R Reynaga, A Jozic, J Kim, E Bloom, R Spears, ... Investigative Ophthalmology & Visual Science 64 (8), 785-785, 2023 | | 2023 |
mRNA Vaccine Against Fibroblast Activation Protein Ameliorates Murine Models of Inflammatory Arthritis X Zhang, A Jozic, P Song, Q Xu, X Shi, H Wang, L Bishop, H Struthers, ... ARTHRITIS & RHEUMATOLOGY 74, 4326-4327, 2022 | | 2022 |
Abstract PO-087: Novel high-throughput screen in a breast cancer cell line to identify potent radiosensitizers MR Landry, AN DuRoss, E Choi, A Jozic, D Nelson, C Sun Clinical Cancer Research 27 (8_Supplement), PO-087-PO-087, 2021 | | 2021 |